CRTC2 enhances HBV transcription and replication by inducing PGC1α expression

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Tian, Xiaohui ^a   Zhao, Fei ^a   Sun, Weihua ^b   Zhi, Xiaoguang ^a   Cheng, Zhikui ^a   Zhou, Ming ^a   Hu, Kanghong ^a,b  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b HUBEI UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

CRTC2; Forskolin; HBV; PGC1 ; Phosphorylation defective CRTC2 mutant

Indexed keywords

CORE PROTEIN; CREB REGULATED TRANSCRIPTION COACTIVATOR 2; FORSKOLIN; LUCIFERASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA REPLICATION; GENE EXPRESSION; GENE SILENCING; HEPATITIS B VIRUS; LUCIFERASE ASSAY; NONHUMAN; PLASMID; REAL TIME POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSCRIPTION; WESTERN BLOTTING; WILD TYPE;

ARTIFICIAL GENE FUSION; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL LINE; GENE EXPRESSION; GENE SILENCING; GENES, REPORTER; HEPATITIS B VIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; LUCIFERASES; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 84896744702     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-30     Document Type: Article

References (37)

1. Hepatitis B viruses: reverse transcription a different way. Nassal M, Virus Res 2008 134 235 249 10.1016/j.virusres.2007.12.024 18339439
2. The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon. Shlomai A, Shaul Y, Med Hypotheses 2008 71 53 57 10.1016/j.mehy.2007.08.032 18334285
3. A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation. Quasdorff M, Hosel M, Odenthal M, Zedler U, Bohne F, Gripon P, Dienes HP, Drebber U, Stippel D, Goeser T, Protzer U, Cell Microbiol 2008 10 1478 1490 10.1111/j.1462-5822.2008.01141.x 18346225
4. Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Bar-Yishay I, Shaul Y, Shlomai A, Liver Int 2011 31 282 290 10.1111/j.1478-3231.2010.02423.x 21281428
5. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussouar F, Brindle P, Takemori H, Montminy M, Nature 2005 437 1109 1111 10.1038/nature03967 16148943
6. Enhancer I predominance in hepatitis B virus gene expression. Doitsh G, Shaul Y, Mol Cell Biol 2004 24 1799 1808 10.1128/MCB.24.4.1799-1808.2004 14749394
7. Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha. Ramiere C, Scholtes C, Diaz O, Icard V, Perrin-Cocon L, Trabaud MA, Lotteau V, Andre P, J Virol 2008 82 10832 10840 10.1128/JVI.00883-08 18768987
8. Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. Wang Y, Li G, Goode J, Paz JC, Ouyang K, Screaton R, Fischer WH, Chen J, Tabas I, Montminy M, Nature 2012 485 128 132 10.1038/nature10988 22495310
9. Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity. Wang Y, Inoue H, Ravnskjaer K, Viste K, Miller N, Liu Y, Hedrick S, Vera L, Montminy M, Proc Natl Acad Sci U S A 2010 107 3087 3092 10.1073/pnas.0914897107 20133702
10. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S, Guzman E, Niessen S, Yates JR 3rd, Takemori H, Okamoto M, Montminy M, Cell 2004 119 61 74 10.1016/j.cell.2004.09.015 15454081
11. TORCs: transducers of regulated CREB activity. Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB, Montminy M, Mol Cell 2003 12 413 423 10.1016/j.molcel.2003.08.013 14536081
12. CRTC2 (TORC2) contributes to the transcriptional response to fasting in the liver but is not required for the maintenance of glucose homeostasis. Le Lay J, Tuteja G, White P, Dhir R, Ahima R, Kaestner KH, Cell Metab 2009 10 55 62 10.1016/j.cmet.2009.06.006 19583954
13. The X protein of hepatitis B virus coactivates potent activation domains. Haviv I, Vaizel D, Shaul Y, Mol Cell Biol 1995 15 1079 1085 7823923
14. Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development. Reese V, Ondracek C, Rushing C, Li L, Oropeza CE, McLachlan A, Int J Biochem Cell Biol 2011 43 230 237 10.1016/j.biocel.2009.11.016 19941970
15. GCN5 acetyltransferase inhibits PGC1alpha-induced hepatitis B virus biosynthesis. Tian X, Zhao F, Cheng Z, Zhou M, Zhi X, Li J, Hu K, Virol Sin 2013 28 216 222 10.1007/s12250-013-3344-3 23913178
16. The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription. Shlomai A, Shaul Y, Biochem Biophys Res Commun 2009 381 544 548 10.1016/j.bbrc.2009.02.078 19233123
17. PGC-1alpha controls hepatitis B virus through nutritional signals. Shlomai A, Paran N, Shaul Y, Proc Natl Acad Sci U S A 2006 103 16003 16008 10.1073/pnas.0607837103 17043229
18. The metabolic regulator PGC-1alpha links anti-cancer cytotoxic chemotherapy to reactivation of hepatitis B virus. Mouler Rechtman M, Burdelova EO, Bar-Yishay I, Ben-Yehoyada M, Fishman S, Halpern Z, Shlomai A, J Viral Hepat 2013 20 34 41 23231082
19. Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha. Rechtman MM, Har-Noy O, Bar-Yishay I, Fishman S, Adamovich Y, Shaul Y, Halpern Z, Shlomai A, FEBS Lett 2010 584 2485 2490 10.1016/j.febslet.2010.04.067 20434445
20. Role of peroxisome proliferator-activated receptor gamma coactivator 1alpha in AKT/PKB-mediated inhibition of hepatitis B virus biosynthesis. Ondracek CR, McLachlan A, J Virol 2011 85 11891 11900 10.1128/JVI.00832-11 21880746
21. Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter. Choi BH, Park GT, Rho HM, J Biol Chem 1999 274 2858 2865 10.1074/jbc.274.5.2858 9915821
22. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Altarejos JY, Montminy M, Nat Rev Mol Cell Biol 2011 12 141 151 10.1038/nrm3072 21346730
23. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Jansson D, Ng AC, Fu A, Depatie C, Al Azzab M, Screaton RA, Proc Natl Acad Sci U S A 2008 105 10161 10166 10.1073/pnas. 0800796105 18626018
24. Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteins. Bittinger MA, McWhinnie E, Meltzer J, Iourgenko V, Latario B, Liu X, Chen CH, Song C, Garza D, Labow M, Curr Biol 2004 14 2156 2161 10.1016/j.cub.2004.11.002 15589160
25. Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes. Saberi M, Bjelica D, Schenk S, Imamura T, Bandyopadhyay G, Li P, Jadhar V, Vargeese C, Wang W, Bowman K, Zhang Y, Polisky B, Olefsky JM, Am J Physiol Endocrinol Metab 2009 297 1137 E1146 10.1152/ajpendo.00158.2009 19706791
26. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Liu Y, Dentin R, Chen D, Hedrick S, Ravnskjaer K, Schenk S, Milne J, Meyers DJ, Cole P, Yates J 3rd, Olefsky J, Guarente L, Montminy M, Nature 2008 456 269 273 10.1038/nature07349 18849969
27. Hepatic glucose sensing via the CREB coactivator CRTC2. Dentin R, Hedrick S, Xie J, Yates J 3rd, Montminy M, Science 2008 319 1402 1405 10.1126/science.1151363 18323454
28. Mechanism of CREB recognition and coactivation by the CREB-regulated transcriptional coactivator CRTC2. Luo Q, Viste K, Urday-Zaa JC, Senthil Kumar G, Tsai WW, Talai A, Mayo KE, Montminy M, Radhakrishnan I, Proc Natl Acad Sci U S A 2012 109 20865 20870 10.1073/pnas.1219028109 23213254
29. Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells. Wu Z, Huang X, Feng Y, Handschin C, Gullicksen PS, Bare O, Labow M, Spiegelman B, Stevenson SC, Proc Natl Acad Sci U S A 2006 103 14379 14384 10.1073/pnas.0606714103 16980408
30. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, Gonzalez FJ, Spiegelman BM, Proc Natl Acad Sci U S A 2003 100 4012 4017 10.1073/pnas.0730870100 12651943
31. Distinct regulation of hepatitis B virus biosynthesis by peroxisome proliferator-activated receptor gamma coactivator 1alpha and small heterodimer partner in human hepatoma cell lines. Ondracek CR, Reese VC, Rushing CN, Oropeza CE, McLachlan A, J Virol 2009 83 12545 12551 10.1128/JVI.01624-09 19793803
32. Peroxisome proliferator-activated receptor gamma Coactivator 1alpha and small heterodimer partner differentially regulate nuclear receptor-dependent hepatitis B virus biosynthesis. Ondracek CR, Rushing CN, Reese VC, Oropeza CE, McLachlan A, J Virol 2009 83 12535 12544 10.1128/JVI.01623-09 19793822
33. Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes. Hoerger TJ, Schillie S, Wittenborn JS, Bradley CL, Zhou F, Byrd K, Murphy TV, Diabetes Care 2013 36 63 69 10.2337/dc12-0759 22933435
34. Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Li-Ng M, Tropp S, Danoff A, Bini EJ, Dig Liver Dis 2007 39 549 556 10.1016/j.dld.2007.02.014 17416560
35. Effects of interferon-alpha/beta on HBV replication determined by viral load. Tian Y, Chen WL, Ou JH, PLoS Pathog 2011 7 1002159 10.1371/journal.ppat. 1002159 21829354
36. A system for stable expression of short interfering RNAs in mammalian cells. Brummelkamp TR, Bernards R, Agami R, Science 2002 296 550 553 10.1126/science.1068999 11910072
37. Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells. Guo H, Jiang D, Ma D, Chang J, Dougherty AM, Cuconati A, Block TM, Guo JT, J Virol 2009 83 847 858 10.1128/JVI.02008-08 18971270